Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,620 | -66,966 | -9,058 | -119,758 | -202,115 |
| Depreciation Amortization | 5,524 | 4,730 | 4,641 | 12,268 | 12,865 |
| Accounts receivable | -9,063 | 6,058 | 45,855 | -45,836 | 12,696 |
| Accounts payable and accrued liabilities | -280 | -1,530 | 1,281 | -10,860 | 7,125 |
| Other Working Capital | -28,331 | 1,392 | 53,316 | -6,130 | 20,259 |
| Other Operating Activity | 25,730 | -12,057 | -174,240 | 83,357 | 5,340 |
| Operating Cash Flow | $-81,040 | $-68,373 | $-78,205 | $-86,959 | $-143,830 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -112,194 | 112,843 | -78,384 | 74,338 | -30,408 |
| PPE Investments | -1,903 | -3,546 | -1,700 | -3,623 | -6,201 |
| Other Investing Activity | 0 | 40,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-114,097 | $149,297 | $-80,084 | $70,715 | $-36,609 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 129 | 3,435 | 1,169 | 1,659 | 122,777 |
| Other Financing Activity | 69,385 | -2,475 | 149,192 | 0 | 0 |
| Financing Cash Flow | $69,514 | $960 | $150,361 | $1,659 | $122,777 |
| Beginning Cash Position | 182,840 | 100,956 | 108,884 | 123,469 | 181,131 |
| End Cash Position | 57,217 | 182,840 | 100,956 | 108,884 | 123,469 |
| Net Cash Flow | $-125,623 | $81,884 | $-7,928 | $-14,585 | $-57,662 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,040 | -68,373 | -78,205 | -86,959 | -143,830 |
| Capital Expenditure | -1,914 | -3,706 | -1,764 | -3,623 | -6,201 |
| Free Cash Flow | -82,954 | -72,079 | -79,969 | -90,582 | -150,031 |